PARLIAMENT of CANADA

PARLINFO

DYCK, The Hon. Lillian Eva, B.A. Hon., M.Sc., Ph.D., D.Litt.
Picture of DYCK, The Hon. Lillian Eva, B.A. Hon., M.Sc., Ph.D., D.Litt.
© Senate
Current Senator - Saskatchewan, Saskatchewan
Place of Birth: North Battleford, Saskatchewan, Canada
Profession | Occupation: Activist, dean (associate), neurochemist, professor, researcher, scientist
Notes: Member of the Gordon First Nation. Cree
Selected Publications This bibliography includes books, chapters in books and journal articles written, edited, compiled or translated solely by the parliamentarian or with others.

Every effort has been made to ensure the accuracy of the following information. Should you find any errors or omissions, please contact us at the following e-mail address: parlinfo@parl.gc.ca

^ Sole Author Books

  • An in vitro study of the uptake and release of m- and p-tyramine .
    Thesis (Ph.D.) -- University of Saskatchewan; 1981. xiii, 157 leaves.

  • Identification and metabolism of certain biogenic amines in brain: a thesis submitted to the Faculty of Graduate Studies in partial fulfilment of the requirements for the degree of Master of Science in the Department of Biochemistry .
    Saskatoon, Sask. : s.n.; 1970. x, 95 leaves.


Chapters in Books

  • Dare to be brave: stand up for yourself.
    In : Women in the Canadian academic tundra: challenging the chill / [edited by] Elena Hannah, Linda Paul, Swani Vethamany-Globus. Montreal : McGill-Queen's University Press; c2002. p. 47-50.


Articles

  • Absence of the atypical mitochondrial aldehyde dehydrogenase (ALDH2) isozyme in Saskatchewan Cree Indians.
    Human Heredity. 43 (2):116-20 Mar./Apr. 1993.

  • The behavioural effects of phenelzine and phenylethylamine may be due to amine release.
    Brain Research Bulletin. 12 (1):23-8 Jan. 1984.

  • Effect of decarboxylase inhibitors on brain p-tyrosine levels.
    Biochemical Pharmacology. 36 (8):1373-6 Apr. 15, 1987.

  • Effect of monofluoromethyldopa (MFMD) on trace amine levels.
    Life Sciences. 40 (6):571-5 Feb. 9, 1987.

  • Inhibition of polyphosphoinositide turnover in rat cerebral cortex by clonidine.
    Life Sciences. 45 (11):993-9 1989.

  • Isoenzymes of aldehyde dehydrogenase in human lymphocytes.
    Alcoholism, Clinical and Experimental Research. 14 (4):534-8 Aug. 1990.

  • Methylphenidate-like stimulants in vitro release [3H]tyramines but not [14C]dopamine.
    European Journal of Pharmacology. 69 (3):371-4 Jan. 29, 1981.

  • Polymorphism of a class 3 aldehyde dehydrogenase present in human saliva and in hair roots.
    Alcoholism, Clinical and Experimental Research. 19 (2):420-6 Apr. 1995.

  • Release of monoamines from striatal slices by phenelzine and beta-phenylethylamine.
    Progress in Neuro-psychopharmacology & Biological Psychiatry. 7 (4):797-800 1983.

  • Release of radiolabeled dopamine, p-tyramine, and m-tyramine from rat striatal slices by some aminotetralins.
    Neurochemical Research. 6 (4):365-75 Apr. 1981.

  • Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor.
    Life Sciences. 44 (17):1149-56 1989.

  • Tryptamine transport in rat brain slices: a comparison with 5-hydroxytryptamine.
    Neurochemical Research. 9 (95):617-28 May 1984.

  • The University of Saskatchewan: a portrait.
    Women's Education. 9 (2):23 1991.

  • Uptake and release of meta-tyramine, para-tyramine, and dopamine in rat striatal slices.
    Neurochemical Research. 3 (6):775-91 Dec. 1978.


^ Multiple Authors Articles

  • A comparison of the effects of methylphenidate and amphetamine on the simultaneous release of radiolabelled dopamine and p- or m-tyramine from rat striatal slices. Dyck, Lillian E., A. A. Boulton and R. S. Jones
    European Journal of Pharmacology. 68 (1):33-40 Nov. 7, 1980.

  • Acceleration of the biosynthesis of rat striatal dopamine by incubation and by administration of gamma-butyrolactone. Dyck, Lillian E. and C. W. Kazakoff
    Journal of Neuroscience Research. 8 (1):57-65 1982.

  • Aliphatic N-methylpropargylamines: monoamine oxidase-B inhibitors and antiapoptotic drugs. Boulton, A. A., P. H. Yu, B. A. Davis, I. A. Paterson, X.M. Li, A. V. Juorio, D. A. Durden and Lillian E. Dyck
    Advances in Pharmacology. 42:308-11 1998.

  • Alterations in trace amine and trace acid concentrations in isolated aggressive mice. Dourish, C. T., B. A. Davis, L. E. Dyck, R. S. Jones and A. A. Boulton
    Pharmacology, Biochemistry, and Behavior. 17 (6):1291-4 Dec. 1982.

  • Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells. Shao, Zongjun, Lillian E. Dyck, Haitao Wang and Xin-Min Li
    Journal of Psychiatry and Neuroscience. 31 (1):32-7 Jan. 2006.

  • Atypical antipsychotics attenuate neurotoxicity of beta-amyloid(25-35) by modulating Bax and Bcl-X(l/s) _expression and localization. Wei, Z., D. D. Mousseau, J. S. Richardson, Lillian E. Dyck and X-M Li
    Journal of Neuroscience Research. 74 (6):942-7 Dec .15, 2003.

  • Behavioural and neurochemical effects of meta-tyrosine in the rat. Dyck, Lillian E., C. W. Kazakoff and C. T. Dourish
    Progress in Neuro-psychopharmacology & Biological Psychiatry. 6 (4):389-94 1982.

  • Biosynthesis and excretion of meta and para tyramine in the rat. Boulton, A. A. and Lillian E. Dyck
    Life Sciences. 14 (12):2497-506 June 16, 1974.

  • The biosynthesis of p-tyramine, m-tyramine, and beta-phenylethylamine by rat striatal slices. Dyck, Lillian E., C. R. Yang and A. A. Boulton
    Journal of Neuroscience Research. 10 (2):211-20 1983.

  • Biphasic behavioural stimulation induced by a monoamine oxidase-inhibiting antidepressant. Dourish, C.T., A. A. Boulton and Lillian E. Dyck
    Progress in Neuro-psychopharmacology & Biological Psychiatry. 6 (4):383-8 1982.

  • Changes in brain catecholamine levels following DL-dopa are not potentiated by deuterium substitution. Dewar, K. M., Lillian E. Dyck, D. A. Durden and A. A. Boulton
    Progress in Neuro-psychopharmacology & Biological Psychiatry. 9 (5):675-80 1985.

  • Conjugation of phenylacetic acid and m- and p-hydroxyphenylacetic acids in the rat striatum. Dyck, Lillian E., D. A. Durden and A. A. Boulton
    Life Sciences. 53 (11):901-9 1993.

  • Cutaneous vasomotor sensitivity to ethanol and acetaldehyde: subtypes of alcohol-flushing response among Chinese. Yu, P. H., C. Y. Fang and Lillian E. Dyck
    Alcoholism, Clinical and Experimental Research. 14 (6):932-6 Dec. 1990.

  • Demonstration of an anti-oxidative stress mechanism of quetiapine. Xu, Haiyun, Haitao Wang, Lixia Zhuang, Bin Yan, Yingxin Yu, Zelan Wei, Yanbo Zhang, Lillian E. Dyck, Steven J. Richardson, Jue He, Xiaokun Li, Jiming Kong and Xin-Min Li
    FEBS Journal. 275 (14):3718-28 Jul. 2008.

  • Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase. Dyck, Lillian E., A. V. Juorio, D. A. Durden and A. A. Boulton
    Naunyn-Schmiedeberg’s Archives of Pharmacology. 337 (3):279-83 Mar. 1988.

  • Effect of deuterium substitution on the disposition of intraperitoneal tryptamine. Dyck Lillian E. and A. A. Boulton
    Biochemical Pharmacology. 35 (17):2893-6 Sept. 1, 1986.

  • Effect of deuterium substitution on the penetration of beta-phenylethylhydrazine into the rat brain. Dewar, K. M., Lillian E. Dyck, D. A. Durden and A. A. Boulton
    Biochemical Pharmacology. 37 (13):2703-4 July 1, 1988.

  • The effect of some drugs on the urinary excretion of some aryl alkyl amines in the rat. Dyck, Lillian E. and A. A. Boulton
    Research Communications in Chemical Pathology and Pharmacology. 11 (1):73-7 May 1975.

  • Effects of antidepressant drugs on inositol phospholipid hydrolysis in rat cerebral cortical slices. Dyck, Lillian E. and A. A. Boulton
    Neurochemical Research. 14 (11):1047-52 Nov. 1989.

  • Effects of beta-phenylethylamine on polyphosphoinositide turnover in rat cerebral cortex. Dyck, Lillian E. and A. A. Boulton
    Neurochemical Research. 14 (1):63-7 Jan. 1989.

  • Effects of deuterium substitution on the catabolism of beta-phenylethylamine: an in vivo study. Dyck, Lillian E., D. A. Durden and A. A. Boulton
    Journal of Neurochemistry. 46 (2):399-404 Feb. 1986.

  • Effects of monoamine oxidase inhibitors on the acid metabolites of some trace amines and of dopamine in the rat striatum. Dyck, Lillian E., D. A. Durden and A. A. Boulton
    Biochemical Pharmacology. 45:1317-22 Mar. 24, 1993.

  • Formation of beta-phenylethylamine from the antidepressant, beta-phenylethylhydrazine. Dyck, Lillian E., D. A. Durden and A. A. Boulton
    Biochemical Pharmacology. 34 (1):1925-9 June 1, 1985.

  • Hydroxylation of beta-phenylethylamine in the rat. Boulton, A. A., Lillian E. Dyck and D. A. Durden
    Life Sciences. 15 (9):1673-83 Nov. 1, 1974.

  • The in vitro release of endogenous m-tyramine, p-tyramine and dopamine from rat striatum. Dyck, L. E., A. V. Juorio and A. A. Boulton
    Neurochemical Research. 7 (6):705-16 June 1982.

  • Inhibition of aromatic L-amino acid decarboxylase and tyrosine aminotransferase by the monoamine oxidase inhibitor phenelzine. Dyck, Lillian E. and K. M. Dewar
    Journal of Neurochemistry. 46 (6):1899-903 June 1986.

  • Inibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine. Dyck, Lillian E. and B. A. Davis
    Drug Metabolism and Disposition. 29 (8):1156-61 Aug. 2001.

  • Involvement of brain trace amines in the behavioural effects of phenelzine. Dewar, K. M., Lillian E. Dyck, D. A. Durden and A. A. Boulton
    Neurochemical Research. 13 (2):113-9 Feb. 1988.

  • Metabolism and pharmacokinetics, in the rat, of (R)-N-(2-Heptyl)Methyl-propargylamine (R-2HMP), a new potent monoamine oxidase inhibitor and antiapoptotic agent. Durden, D.A., Lillian E. Dyck, B. A. Davis, Y.D. Liu and A. A. Boulton
    Drug Metabolism and Disposition. 28 (2):147-54 Feb. 2000.

  • Microassay for the estimation of monoamine oxidase activity. Wu, P. H. and Lillian E. Dyck
    Analytical Biochemistry. 72:637-42 May 7, 1976.

  • Olanzapine and quetiapine protect PC12 cells from beta-amyloid peptide(25-35)-induced oxidative stress and the ensuing apoptosis. Wang, H., H. Xu, Lillian E. Dyck and X-M Li
    Journal of Neuroscience Research. 81 (4):572-80. Aug. 15, 2005.

  • Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution. Dourish, C. T., K. M. Dewar, Lillian E. Dyck and A. A. Boulton
    Psychopharmacology. 81 (2):122-5 1983.

  • Potentiation of the biochemical effects of beta-phenylethylhydrazine by deuterium substitution. Dyck, Lillain E., D. A. Durden, P. H. Yu, B. A. Davis and A. A. Boulton
    Biochemical Pharmacology. 32 (9):1519-22 May 1, 1983.

  • Reversible amine -- selective effects of acute and chronic brofaromine treatment in the rat. Dyck, Lillian E. and A. A. Boulton
    Life Sciences. 51 (1):59-66 1992.

  • The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat. Dyck, Lillian E, C. W. Kazakoff and C. T. Dourish
    European Journal of Pharmacology. 84 (3):139-49 Oct. 22, 1982.

  • Uptake of para-tyramine and meta-tyramine into slices of the caudate nucleus and hypothalamus of the rat. Petrali, E.H., A. A. Boulton and Lillian E. Dyck
    Neurochemical Research. 4 (5):633-42 Oct. 1979.


^



© Library of Parliament